|Articles|July 1, 2000

July 2000
Volume 6
Issue 7

Mandated Managed Care for Blind and Disables Medicaid Beneficiaries in a County-Organized Health System: Implementation Challenges and Access Issues

Author(s)Zeina C. Hawkinson, PhD, Janice E. Frates, PhD

Download PDF: Mandated Managed Care for Blind and Disables Medicaid Beneficiaries in a County-Organized Health System: Implementation Challenges and Access Issues

Articles in this issue

about 26 years ago

Article

Improving the Sensitivity of Cervical Cytology: What Are the Issues?

about 26 years ago

Article

Why Are Drug Prices Lower in Canada?

about 26 years ago

Article

Comparing the Medical Expenses of Children with Medicaid and Commercial Insurance in an HMO

about 26 years ago

Article

Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity

about 26 years ago

Article

High-Risk Population Health Management -- Achieving Improved Patient Outcomes and Near-Term Financial Results

about 26 years ago

Article

Design and Implementation of an Inpatient Disease Management Program

about 26 years ago

Article

Managing Drug Costs: The Perception of Managed Care Pharmacy Directors

about 26 years ago

Article

Interactive Voice Response Systems in the Diagnosis and Management of Chronic Disease

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Mandated Managed Care for Blind and Disables Medicaid Beneficiaries in a County-Organized Health System: Implementation Challenges and Access Issues

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Medicaid MFN Pricing Could Save $8.6 Billion

Active US Drug Shortages Rise for Third Straight Quarter

Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD